XML 22 R11.htm IDEA: XBRL DOCUMENT v3.25.3
Net revenues
 9 Months Ended
Sep. 28, 2025
Revenue from Contract with Customer [Abstract]  
Net revenues Net revenues
We primarily generate revenue from the sale of medical devices including single use disposable devices and, to a lesser extent, reusable devices, instruments and capital equipment. Revenue is recognized when obligations under the terms of a contract with our customer are satisfied; this occurs upon the transfer of control of the products. Generally, transfer of control to the customer occurs at the point in time when our products are shipped from the manufacturing or distribution facility. For our Original Equipment and Development Services ("OEM") product category, included within our Americas segment, most revenue is recognized over time because OEM generates revenue from the sale of custom products that have no alternative use and we have an enforceable right to payment to the extent that performance has been completed. We market and sell products through our direct sales force and distributors to customers within the following end markets: (1) hospitals and healthcare providers; (2) other medical device manufacturers; and (3) home care providers, which constituted 88%, 10% and 2% of consolidated net revenues, respectively, for the nine months ended September 28, 2025. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods. With respect to the custom products sold in OEM, revenue is measured using the units produced output method. Payment is generally due 30 days from the date of invoice.
The following table disaggregates revenue by global product category for the three and nine months ended September 28, 2025 and September 29, 2024.
Three Months EndedNine Months Ended
September 28, 2025September 29, 2024September 28, 2025September 29, 2024
Vascular access$191,021 $180,896 $558,919 $543,355 
Interventional
266,412 149,865 573,990 425,687 
Anesthesia101,449 101,154 284,429 299,997 
Surgical122,879 111,746 342,706 328,574 
Interventional urology71,770 83,395 219,125 246,241 
OEM80,412 82,558 222,971 259,080 
Other (1)
79,078 54,761 192,439 148,981 
Net revenues (2)
$913,021 $764,375 $2,394,579 $2,251,915 
(1)    Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products) as well as adjustments in our reserves related to the Italian payback measure pertaining to prior years. Refer to Note 13 for additional information.
(2)    The product categories listed above are presented on a global basis, as each of our reportable segments are defined based on the geographic location of its operations.